ESTHMR إستثمر

Minapharm Pharmaceuticals MIPH

مينا فارم للأدوية والصناعات الكيماوية

Health Care & PharmaceuticalsEgyptian Exchange

812.49 EGP

+4.21%

Close of Thu 1 Oct 2026

Market value
EGP 9.57bn
Highest and lowest close in a year
250.00 – 941.03
Shares traded in the session
1,741
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Established in October 1986 and based in Cairo, Egypt, Minapharm Pharmaceuticals is a public company operating within the pharmaceuticals, biotechnology & life sciences sector, focusing on pharmaceuticals. Listed on the Egyptian Exchange since January 2004, it is majority-owned by Triquera BV with a 79.59% stake. The company holds stakes in ProBioGen AG (99.19%), Minapharm for Trade and Distribution (95.0%), Migentra Egypt Healthcare Transforming Medicines (75.01%), and MiGenTra- GmbH (49.0%).

Facts from Mubasher

Its record at the exchange

Minapharm Pharmaceuticals accumulated 577 filings on the EGX between 2010 and 2026, reaching its highest activity in 2022 with 58 filings. Across 62 reported periods from 2013 to 2026, the company posted 4 loss-making periods, achieving its highest reported net profit of 631 million EGP in FY 2022 and its lowest net result of -90 million EGP in H1 2024. Its trading was suspended and resumed 9 times, and it completed its first capital decrease in 11 years on 2026-02-03.

Its latest filings at the exchange

  1. Board decisionsMinapharm Pharmaceuticals and Chemical Industries (MIPH.CA) - Company Board of Directors Meeting Minutes
  2. ResultsMinapharm Pharmaceuticals and Chemical Industries (MIPH.CA) announces its standalone financial results for the period from 01/01/2026 to 30/06/2026
  3. StatementStatement from Minapharm Pharmaceuticals (MIPH.CA)

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Insider / Board Sold10,790 (0.09% of the company)Bulletin ↗
  2. Insider / Board Bought10,790 (0.09% of the company)Bulletin ↗
  3. Insider / Board Sold11,000 (0.09% of the company)Bulletin ↗
  4. Insider / Board Bought11,000 (0.09% of the company)Bulletin ↗
  5. Insider / Board Sold1 (less than 0.01% of the company)Bulletin ↗
  6. Insider / Board Bought1,647 (0.01% of the company)Bulletin ↗
  7. Insider / Board Bought1 (less than 0.01% of the company)Bulletin ↗
  8. Insider / Board Bought7,220 (0.06% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.